Palkion
Stage
Series C | AliveTotal Raised
$2.5MLast Raised
$2.5M | 14 yrs agoMissing: Palkion's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Palkion's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Palkion
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Palkion is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
1,568 items
Palkion Frequently Asked Questions (FAQ)
Where is Palkion's headquarters?
Palkion's headquarters is located at 4365 Executive Drive, San Diego.
What is Palkion's latest funding round?
Palkion's latest funding round is Series C.
How much did Palkion raise?
Palkion raised a total of $2.5M.
Who are the investors of Palkion?
Investors of Palkion include CrystalGenomics and ProQuest Investments.
Who are Palkion's competitors?
Competitors of Palkion include Humanetics, Arena Pharmaceuticals, Viracta Therapeutics, Ikaria, Akebia Therapeutics and 12 more.
Compare Palkion to Competitors
Humanetics is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and wellbeing in markets with urgent and unmet needs. It has a focus on radiation modulators for oncology, medical imaging, and medical countermeasure uses. The company develops BIO 300, a highly selective modulator of inflammation, cell cycle arrest, and DNA damage repair. Humanetics was founded in 1988 and is based in Minneapolis, Minnesota.
SBIO is focused on the discovery and development of small molecule oncology drugs.
CoImmune, fka Argos Therapeutics, is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases. Using biological components from each patient, the company's immunotherapies employ the patient's dendritic cells to activate an immune response specific to the patient's disease.
ThyroChek is the only available rapid test for elevated TSH approved by the FDA. It is a rapid, qualitative test for elevated TSH, thyroid stimulating hormone, a clinical indicator of hypothyroidism. Screening Devices Canada is producing products for the thyroid health market in the United States which is a market valued at $1.2B annually.
Neuronascent is focused on the discovery and development of therapies for Alzheimer's disease, depression, and stroke based on the science of neurogenesis that: (1) Reduce the loss of neurons (2) Restore and replace damaged neurons (3) Promote the formation of new neurons (4) Reverse cognitive loss
Calyx Therapeutics is a pharmaceutical company focusing on oral therapies for diabetes and inflammatory diseases. Calyx utilizes natural plant extracts with demonstrated clinical activity in humans as the source of its discovery efforts. The company isolates the biologically active molecule, determines its chemical structure, and aims to develop small molecule analogs. This process aims to reduce the time and investment required to take lead molecules into preclinical and clinical testing.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.